Suzanne K. Vosburg

3.9k total citations
68 papers, 2.9k citations indexed

About

Suzanne K. Vosburg is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Suzanne K. Vosburg has authored 68 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Public Health, Environmental and Occupational Health, 25 papers in Pharmacology and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Suzanne K. Vosburg's work include Opioid Use Disorder Treatment (27 papers), Cannabis and Cannabinoid Research (15 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). Suzanne K. Vosburg is often cited by papers focused on Opioid Use Disorder Treatment (27 papers), Cannabis and Cannabinoid Research (15 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). Suzanne K. Vosburg collaborates with scholars based in United States, France and Germany. Suzanne K. Vosburg's co-authors include Sandra D. Comer, Richard W. Foltin, Margaret Haney, Carl L. Hart, Maria A. Sullivan, Ziva D. Cooper, Jeanne M. Manubay, Eric Rubin, Jermaine D. Jones and William J. Kowalczyk and has published in prestigious journals such as Biological Psychiatry, Pain and Neuropsychopharmacology.

In The Last Decade

Suzanne K. Vosburg

67 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne K. Vosburg United States 33 1.2k 964 680 594 505 68 2.9k
Adam Bisaga United States 36 874 0.7× 1.3k 1.4× 1.1k 1.6× 1.2k 2.0× 571 1.1× 114 3.6k
Chris‐Ellyn Johanson United States 29 528 0.4× 1.0k 1.1× 688 1.0× 562 0.9× 454 0.9× 49 2.6k
Alison Oliveto United States 28 747 0.6× 1.1k 1.2× 623 0.9× 614 1.0× 336 0.7× 103 2.5k
Lon R. Hays United States 28 594 0.5× 1.2k 1.2× 376 0.6× 436 0.7× 470 0.9× 88 2.3k
John J. Mariani United States 26 825 0.7× 655 0.7× 446 0.7× 647 1.1× 274 0.5× 67 2.1k
Michael Soyka Germany 28 350 0.3× 720 0.7× 561 0.8× 1.3k 2.1× 332 0.7× 136 3.1k
Michael Soyka Germany 33 451 0.4× 935 1.0× 393 0.6× 1.2k 2.0× 481 1.0× 187 4.1k
Marc L. Copersino United States 24 660 0.6× 490 0.5× 295 0.4× 700 1.2× 388 0.8× 42 2.0k
C. H. Ashton United Kingdom 21 1.2k 1.0× 422 0.4× 173 0.3× 349 0.6× 364 0.7× 44 2.5k
Albert J. Arias United States 26 331 0.3× 676 0.7× 258 0.4× 979 1.6× 231 0.5× 57 2.7k

Countries citing papers authored by Suzanne K. Vosburg

Since Specialization
Citations

This map shows the geographic impact of Suzanne K. Vosburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne K. Vosburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne K. Vosburg more than expected).

Fields of papers citing papers by Suzanne K. Vosburg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne K. Vosburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne K. Vosburg. The network helps show where Suzanne K. Vosburg may publish in the future.

Co-authorship network of co-authors of Suzanne K. Vosburg

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne K. Vosburg. A scholar is included among the top collaborators of Suzanne K. Vosburg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne K. Vosburg. Suzanne K. Vosburg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vosburg, Suzanne K., Rebekkah S. Robbins, Kevin M. Antshel, Stephen V. Faraone, & Jody L. Green. (2021). Characterizing Pathways of Non-oral Prescription Stimulant Non-medical Use Among Adults Recruited From Reddit. Frontiers in Psychiatry. 11. 631792–631792. 8 indexed citations
2.
Vosburg, Suzanne K., Maria A. Sullivan, & Sandra D. Comer. (2017). Evaluation of the reinforcing and subjective effects of heroin in combination with dextromethorphan and quinidine. Journal of Opioid Management. 7(6). 451–461. 2 indexed citations
3.
Cooper, Ziva D., Kirk W. Johnson, Suzanne K. Vosburg, et al.. (2017). Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers. Drug and Alcohol Dependence. 178. 340–347. 20 indexed citations
4.
Comer, Sandra D., Shanthi Mogali, Phillip Saccone, et al.. (2013). Effects of Acute Oral Naltrexone on the Subjective and Physiological Effects of Oral D-Amphetamine and Smoked Cocaine in Cocaine Abusers. Neuropsychopharmacology. 38(12). 2427–2438. 45 indexed citations
5.
Vosburg, Suzanne K., Jermaine D. Jones, Jeanne M. Manubay, et al.. (2012). Assessment of a formulation designed to be crush-resistant in prescription opioid abusers. Drug and Alcohol Dependence. 126(1-2). 206–215. 39 indexed citations
6.
Vosburg, Suzanne K., et al.. (2011). Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients. Journal of Opioid Management. 7(1). 47–53. 25 indexed citations
7.
Jones, Jermaine D., Suzanne K. Vosburg, Jeanne M. Manubay, & Sandra D. Comer. (2011). Oxycodone Abuse in New York City: Characteristics of Intravenous and Intranasal Users. American Journal on Addictions. 20(3). 190–195. 24 indexed citations
8.
Jones, Jermaine D., Maria A. Sullivan, Jeanne M. Manubay, Suzanne K. Vosburg, & Sandra D. Comer. (2010). The Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Patients with Chronic, Non-Malignant Pain who are Maintained on Sublingual Buprenorphine/Naloxone. Neuropsychopharmacology. 36(2). 411–422. 25 indexed citations
9.
Kirkpatrick, Matthew G., Margaret Haney, Suzanne K. Vosburg, et al.. (2010). Zolpidem does not serve as reinforcer in humans subjected to simulated shift work. Drug and Alcohol Dependence. 112(1-2). 168–171. 2 indexed citations
10.
Comer, Sandra D., Maria A. Sullivan, Suzanne K. Vosburg, William J. Kowalczyk, & Janet Houser. (2010). Abuse liability of oxycodone as a function of pain and drug use history. Drug and Alcohol Dependence. 109(1-3). 130–138. 40 indexed citations
11.
Comer, Sandra D., Maria A. Sullivan, Suzanne K. Vosburg, et al.. (2010). Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine‐maintained intravenous heroin abusers. Addiction. 105(4). 709–718. 83 indexed citations
12.
Mariani, John J., Margaret Haney, Carl L. Hart, Suzanne K. Vosburg, & Frances R. Levin. (2009). Effects of research setting on observed depressive symptoms in marijuana users. Journal of Substance Abuse Treatment. 37(4). 431–434. 2 indexed citations
13.
Kowalczyk, William J., Maria A. Sullivan, Suzette M. Evans, et al.. (2009). Sex Differences and Hormonal Influences on Response to Mechanical Pressure Pain in Humans. Journal of Pain. 11(4). 330–342. 42 indexed citations
14.
Comer, Sandra D., Maria A. Sullivan, Robert A. Whittington, Suzanne K. Vosburg, & William J. Kowalczyk. (2007). Abuse Liability of Prescription Opioids Compared to Heroin in Morphine-Maintained Heroin Abusers. Neuropsychopharmacology. 33(5). 1179–1191. 125 indexed citations
15.
Haney, Margaret, Carl L. Hart, Suzanne K. Vosburg, et al.. (2007). Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology. 197(1). 157–168. 129 indexed citations
16.
Hart, Carl L., Margaret Haney, Suzanne K. Vosburg, Eric Rubin, & Richard W. Foltin. (2007). Gabapentin does not reduce smoked cocaine self-administration: employment of a novel self-administration procedure. Behavioural Pharmacology. 18(1). 71–75. 22 indexed citations
17.
Haney, Margaret, Erik W. Gunderson, Judith G. Rabkin, et al.. (2007). Dronabinol and Marijuana in HIV-Positive Marijuana Smokers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(5). 545–554. 137 indexed citations
18.
Sullivan, Maria A., Suzanne K. Vosburg, & Sandra D. Comer. (2006). Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin. Psychopharmacology. 189(1). 37–46. 71 indexed citations
19.
McDowell, David M., Edward V. Nunes, Angela Seracini, et al.. (2005). Desipramine treatment of cocaine-dependent patients with depression: A placebo-controlled trial. Drug and Alcohol Dependence. 80(2). 209–221. 38 indexed citations
20.
Vosburg, Suzanne K., Carl L. Hart, Margaret Haney, & Richard W. Foltin. (2005). An evaluation of the reinforcing effects of memantine in cocaine-dependent humans. Drug and Alcohol Dependence. 79(2). 257–260. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026